LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 07-10-2023 19:40
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHC832045*
HEMATOLOGY
Test Description Results Units Reference Range Methodology
CBC
Hemoglobin. 10.7 L g/dl 12.0 - 15.3 Colorimetric
RBC (Red Blood Cell). 4.25 10^6/ul 4.0 - 5.5 Impedance
Hematocrit. 32.9 L % 37.0 - 47.0 Calculated
MCV (Mean Corpuscular Volume). 77.3 L fL 78.0 - 100.0 Calculated
MCH (Mean Corpuscular Hemoglobin). 25.1 L pg/ml 27.0 - 35.0 Calculated
MCHC (Mean Corpuscular Hb. Conc.). 32.5 g/dl 31.0 - 36.0 Calculated
RDW-CV (Red Cell Distribution Width). 16.7 H % 11.5 - 14.8 Calculated
Platelet Count. 221 10^3/ul 150 - 450 Impedance
MPV. 8.2 fL 7 -11 Calculated
WBC (white Blood Cell). 4.30 10^3/uL 4.0 - 10.0 Impedance
Neutrophils%. 55.32 % 40.0 - 75.0 Flow Cytometry
Lymphocytes%. 34.2 % 20.0 - 45.0 Flow Cytometry
Eosinophils%. 2.44 % 0.0 - 6.0 Flow Cytometry
Monocytes%. 7.27 % 2.0 - 10.0 Flow Cytometry
Basophils%. 0.7 % 0.0 - 2.0 Flow Cytometry
Absolute Neutrophils. 2.40 10^3/ul 1.1 - 7.0 Flow Cytometry
Absolute Lymphocytes. 1.49 10^3/ul 0.7 - 5.1 Flow Cytometry
Absolute Eosinophils. 0.11 10^3/ul 0.04 - 0.9 Flow Cytometry
Absolute Monocytes. 0.32 10^3/ul 0.2 - 1.0 Flow Cytometry
Absolute Basophils. 0.03 10^3/ul 0.0 - 0.2 Flow Cytometry
Sample Type: Whole Blood
Remarks: Kindly correlate clinically.
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Farooque SMP
Lab Technician
00198507-002
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 08-10-2023 14:17
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHC832045*
BIOCHEMISTRY
Test Description Results Units Reference Range Methodology
Diabetic Screening.
HbA1c. 7.0 H % < or =5.6 Normal HPLC
5.7-6.4 Pre-diabetes
> or=6.5 Diabetes
Average Blood Glucose (ABG) 154.0 90 - 120 Good Control Calculated
121 - 150 Fair Control
151 - 180 Unsatisfactory
Control
>180 Poor Control
Sample Type: Whole Blood
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Jeemol Nibin
Lab Technician
DHA-P-0137006
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 07-10-2023 19:40
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHCSE944776*
BIOCHEMISTRY
Test Description Results Units Reference Range Methodology
LIPID PROFILE
Cholesterol, Total 222.84 H mg/dl Desirable : < 200 CHOD-POD
Moderate High: 200 - 239
High : >= 240
Triglyceride, 165.41 H mg/dl Normal : <150 GPO-POD
Borderline : 150 - 199
High : >200
HDL-Cholesterol 54.84 mg/dl 40 - 60 Enzymatic
LDL-Cholesterol, 149.52 H mg/dl Optimal : < 100 Enzymatic
Above Optimal : 100 - 129
Borderline: 130 - 159
High: 160 - 189
Very High: > 190
VLDL-Cholestrerol, 33.08 H mg/dl 0 - 30 Calculated
CHOL:HDL Ratio, 4.06 Ratio <5 Calculated
Non-HDL Cholesterol, 168 H mg/dl < 160 Calculated
Sample Type: Serum
Remarks: Kindly correlate clinically.
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Farooque SMP
Lab Technician
00198507-002
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 07-10-2023 20:57
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHCSE944776*
BIOCHEMISTRY
Test Description Results Units Reference Range Methodology
LFT
Bilirubin Total 0.35 mg/dl <1.2 DIAZO
Bilirubin Direct 0.14 mg/dl <= 0.30 DIAZO
Bilirubin, Indirect, 0.21 mg/dl < 1.0 Calculated
Alanine Aminotransferase (ALT/SGPT), 15.10 U/L <33 IFCC without P5P
Aspartate Aminotransferase (AST/SGOT), 16.47 U/L < 32 IFCC without P5P
Alkaline Phosphatase, 61.25 U/L 35 - 105 IFCC
Gamma Glutamyl Transferase 15.83 U/L 6 - 42 Enzymatic
Total Protein. 6.69 g/dl 6.4 - 8.3 Biuret
Albumin, 4.73 g/dl 3.5 - 5.2 Bromocresol green
(BCG)
Globulin, 1.96 L g/dl 2.5 - 3.5 Calculated
A/G Ratio, 2.41 Ratio 1.1 - 2.5 Calculated
Sample Type: Serum
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Farooque SMP
Lab Technician
00198507-002
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 07-10-2023 19:40
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHCSE944776*
BIOCHEMISTRY
Test Description Results Units Reference Range Methodology
Renal Profile
Urea. 18.84 mg/dl 16.6 - 48.5 Urease Kinetic
Creatinine. 0.57 mg/dl 0.50 - 0.90 Modified Jaffe's
Uric Acid 7.12 H mg/dl 2.40 - 5.70 Uricase
Calcium. 9.89 mg/dl 8.8 - 10.2 NM-BAPTA
Urea Nitrogen 8.81 mg/dl 7.7 - 22.60 Calculated
Sample Type: Serum
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Farooque SMP
Lab Technician
00198507-002
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 07-10-2023 19:41
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHCSE944776*
BIOCHEMISTRY
Test Description Results Units Reference Range Methodology
Iron Deficiency Profile.
Iron. 43.45 ug/dl 37.0 - 145.0 Ferrozine
Total iron binding capacity (TIBC) 444.12 H ug/dl 250.0 - 425.0 Calculated
Unsaturated Iron Binding Capacity (UIBC) 400.66 H ug/dl 110 - 370 Ferrozine
Sample Type: Serum
Remarks: Kindly correlate clinically.
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Farooque SMP
Lab Technician
00198507-002
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 07-10-2023 20:57
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHCSE944776*
HORMONES
Test Description Results Units Reference Range Methodology
T3
Tri Iodothyronine-Total (TT3) 1.25 L nmol/L 1.34 - 2.73 CLIA
Sample Type: Serum
Remarks: Kindly correlate clinically.
T4
Thyroxine Total (TT4). 144.95 nmol/L 78.38 - 157.40 CLIA
Sample Type: Serum
Clinical Interpretation:
Interpretation:- Increased with hyperthyroidism, with subacute thyroiditis in its first stage and with thyrotoxicosis due to Hashimoto disease.
Decreased in hypothyroidism and in the third stage of (painful) subacute thyroiditis
TSH
TSH. 1.985 uIU/mL 0.38 - 5.33 CLIA
Reference Range for
Pregnant:
First Trimester: 0.24 - 2.99
Second Trimester: 0.46 -
2.95
Third Trimester: 0.43 - 2.78
Sample Type: Serum
Clinical Interpretation:
Interpretation: High TSH suggests that the person is closer to Hypothyroidism (underactive), and does not have enough thyroid hormone circulating.
Low TSH suggests that the person is closer to Hyperthyroidism (overactive), and has too much thyroid hormone circulating
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Farooque SMP
Lab Technician
00198507-002
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 08-10-2023 11:04
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHCSE944776*
HORMONES
Test Description Results Units Reference Range Methodology
Vitamin B12, Serum
Vitamin B12 448.9 pg/mL 180 - 914 CLIA
Indeterminte : 145 - 180
Deficient Range : 145
Sample Type: Serum
Clinical Interpretation:
Interpretation:- Increase B12 level is seen in Liver disease (such as cirrhosis or hepatitis), Myeloproliferative disorders (for example, polycythemia
vera and chronic myelogenous leukemia). Decreased B12 level is seen in diseases that cause malabsorption (for example, celiac disease and Crohn
disease), Lack of intrinsic factor, a protein that helps the intestine absorb vitamin B12, hyperthyrodisim , pregnancy.
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Jeemol Nibin
Lab Technician
DHA-P-0137006
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 07-10-2023 20:57
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHCSE944776*
HORMONES
Test Description Results Units Reference Range Methodology
VITAMIN D TOTAL ( 25 OH )
Vitamin D (25 Hydroxy, Total) 28.15 L ng/mL Deficiency : <20 CLIA
Insufficiency : 20 - <30
Sufficiency : 30 - 80
Toxicity : > 80
Sample Type: Serum
Clinical Interpretation:
Interpretation: Vit D (25 – OH) is the sum of Vit D2 (25 – OH) and Vit D3 (25 – OH). In normal persons not taking external supplements - Vit D3
comprises approximately 90 % of the total. 25 hydroxy (25–OH) vitamin D3 or calcidiol is the storage form of vitamin D3. Deficiency is associated
with osteoporosis, multiple sclerosis, and rheumatoid arthritis and mood disorders. Both Vitamin D2 and Vitamin D3 are converted to 25–OH
vitamin D3 in the liver. 25 hydroxy vitamin D3 circulates to the kidney where it is converted to 1, 25 hydroxy vitamins D3 or calcitriol, the
functional form of the vitamin. Calcitriol is vital to calcium regulation and low serum calcium causes release of parathormone which converts
25–OH vitamin D3 to 1, 25 –OH vitamin D3 which then triggers osteolysis releasing calcium into the blood stream.
Testosterone Total, Serum
Testosterone Total 0.74 nmol/L 0.35 - 2.61 CLIA
Sample Type: Serum
Clinical Interpretation:
Interpretation:- High amounts of testosterone in the body can lead to a lower sperm count. Low testosterone concentrations can be caused by
testicular failure (primary hypogonadism) or inadequate stimulation by pituitary gonadotropins (secondary hypogonadism).
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Farooque SMP
Lab Technician
00198507-002
LABORATORY REPORT
Patient Name: Ms FAREEDAH MOHAMMAD ABUNASER Collected On: 07-10-2023 11:45
Age/Gender: 69 Y/F Asserted Date: 07-10-2023 15:00
MR No: D2010009949 Authenticated On: 08-10-2023 14:18
Visit No: C211OP0151220 Lab ID No: RH01LB231015414
Referred By: DR.FIDA HUSSAIN HC WALK IN
Final Report *RHCUR223975*
CLINICAL PATHOLOGY
Test Description Results Units Reference Range Methodology
URINE ANALYSIS
PHYSICAL EXAMINATION : .
Colour. yellow Pale Yellow Macroscopy
Appearance. clear Clear Macroscopy
pH. 6.5 4.5 - 8.0 Ionic
Specific Gravity. 1.020 1.003 - 1.035 Ionic
CHEMICAL EXAMINATION : .
Protein. Negative Negative pH
Glucose. Negative Negative GOD-POD
Ketone. Negative Negative Legal's test
Blood. Negative Negative Peroxidase
Bilirubin. Negative Negative DIAZO
Urobilinogen. Normal Negative DIAZO
Nitrate Negative Negative Griess test
Leukocyte Positive ++ Negative Esterase
MICROSCOPIC EXAMINATION : .
WBCs 8-10 H /HPF 0-5 Microscopy
RBCs 0-2 /HPF 0-2 Microscopy
Epithelial Cells. 0-2 /HPF 0 - 10 Microscopy
Crystal. NIL Negative Microscopy
CASTs NIL Microscopy
Bacteria FEW Absent Microscopy
Other NIL
Sample Type: Urine
- - - - END OF REPORT - - - -
Test result pertains only to the sample tested and to be interpreted in the light of clinical history.
Test marked with * are outsourced test. Test marked as # is out of the scope of accreditation with ISO 15189:2012
Dr. Anju Sapra
Specialist Clinical Pathologist
DHA-P-16972866 Jeemol Nibin
Lab Technician
DHA-P-0137006
